Results 161 to 170 of about 8,397 (218)

Leishmanicidal Action of the Peptides 19-4LF, 19-2.5 and 19-2.5LF Topically Administered on Cutaneous Lesions Caused by <i>Leishmania major</i>. [PDF]

Pharmaceutics
El-Dirany R, Ginatta P, Fernández-Rubio C, Burguete-Mikeo A, Larrea E, Martinez-de-Tejada G, Nguewa PA.   +6 more
europepmc   +1 more source

Ferroptosis and Nrf-2 signaling: a redox tug of war in leishmaniasis pathogenesis and host directed therapy. [PDF]

Redox Biol
Dar MJ, Huston RH, Purayil N, Cronin AI, Gondal SA, Nakhasi HL, Brito R, Gannavaram S, Satoskar AR.   +8 more
europepmc   +1 more source

First molecular detection of <i>Leishmania infantum</i> in a domestic cat from Costa Rica. [PDF]

JFMS Open Rep
Sánchez-Bermúdez JF, Pacheco E, García R, Achí L, Zuniga-Moya MJ, Bonilla MC, Dolz G.   +6 more
europepmc   +1 more source

Machine Learning-Based QSAR Models for Discovery of Inhibitors Targeting <i>Leishmania infantum</i> Amastigotes. [PDF]

Pharmaceuticals (Basel)
Flores-Balmaseda N, Rojas-Vargas JA, Rojas-Socarrás S, Pérez-Giménez F, Torrens F, Castillo-Garit JA.   +5 more
europepmc   +1 more source

[A study of experimental cutaneous leishmaniasis in white mice].

Meditsinskaia parazitologiia i parazitarnye bolezni, 1998
openaire   +1 more source

<i>Acomys cahirinus seurati</i> as a Potential Reservoir Host of <i>Leishmania major</i>. [PDF]

Pathogens
Karlin S, Bečvářová B, Benallal KE, Bečvář T, Mezai G, Zaabar M, Mefissel M, Volf P, Sádlová J.   +8 more
europepmc   +1 more source

Early Regulatory and Th2-Associated Responses Shape Resistance to <i>Leishmania panamensis</i> Infection in C57BL/6 Mice. [PDF]

Pathogens
Herrera L, Restrepo CM, Villalobos R, Degracia K, Álvarez J, Fernández PL.   +5 more
europepmc   +1 more source

An Overview of the Factors Related to Leishmania Vaccine Development. [PDF]

Vaccines (Basel)
Passero LFD, Cavallone IN, Araújo Flores GV, de Lima Melchert SS, Laurenti MD.   +4 more
europepmc   +1 more source